 |
인쇄하기
취소
|
Hanmi sets eyes on European markets
Hanmi Pharmaceutical Co. is going all-out to make inroads into European countries as its clopidogrel drug has been recently approved by the Medicines Healthcare products Regulatory Agency (MHRA) in UK.
“We will ramp up our overseas expansion drive, with the aim of becoming a global pharmaceutical firm,” said a company official.
The competition is fierce in Korea's domestic market and the ...
“We will ramp up our overseas expansion drive, with the aim of becoming a global pharmaceutical firm,” said a company official.
The competition is fierce in Korea's domestic market and the ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.